125 related articles for article (PubMed ID: 11028844)
1. Intensive treatment of rheumatoid arthritis reduces need for dialysis due to secondary amyloidosis.
Kaipiainen-Seppänen O; Myllykangas-Luosujärvi R; Lampainen E; Ikäheimo R
Scand J Rheumatol; 2000; 29(4):232-5. PubMed ID: 11028844
[TBL] [Abstract][Full Text] [Related]
2. A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland.
Immonen K; Finne P; Grönhagen-Riska C; Pettersson T; Klaukka T; Kautiainen H; Hakala M
Amyloid; 2011 Mar; 18(1):25-8. PubMed ID: 21284495
[TBL] [Abstract][Full Text] [Related]
3. [Anti-rheumatic therapy in patients with rheumatoid arthritis undergoing hemodialysis].
Akiyama Y
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(6):485-92. PubMed ID: 22214809
[TBL] [Abstract][Full Text] [Related]
4. [Kidney involvement in rheumatoid arthritis].
Icardi A; Araghi P; Ciabattoni M; Romano U; Lazzarini P; Bianchi G
Reumatismo; 2003; 55(2):76-85. PubMed ID: 12874640
[TBL] [Abstract][Full Text] [Related]
5. [Secondary amyloidosis associated with rheumatoid arthritis (RA)].
Koseki Y; Goto M
Nihon Rinsho; 2005 Jan; 63 Suppl 1():278-82. PubMed ID: 15799361
[No Abstract] [Full Text] [Related]
6. End-stage renal disease in patients with rheumatoid arthritis.
Paudyal S; Yang FM; Rice C; Chen CC; Skelton M; Bethel M; Brown S; Nahman NS; Carbone L
Semin Arthritis Rheum; 2017 Feb; 46(4):418-422. PubMed ID: 27591827
[TBL] [Abstract][Full Text] [Related]
7. Intensifying treatment of rheumatoid arthritis with combinations of traditional disease-modifying anti-rheumatic drugs among patients with persistent disease did not reduce the need for large joint surgery.
Kononoff A; Heiskanen J; Lumiaho J; Kautiainen H; Kaipiainen-Seppänen O
Scand J Rheumatol; 2007; 36(6):424-7. PubMed ID: 18092262
[TBL] [Abstract][Full Text] [Related]
8. Periodontitis in early and chronic rheumatoid arthritis: a prospective follow-up study in Finnish population.
Äyräväinen L; Leirisalo-Repo M; Kuuliala A; Ahola K; Koivuniemi R; Meurman JH; Heikkinen AM
BMJ Open; 2017 Jan; 7(1):e011916. PubMed ID: 28143836
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the clinical course of disease and subsequent dialysis therapy in a group of patients with rheumatoid arthritis and end-stage renal disease].
Majdan M; Stepniak C; Piotrowicz S; Broniek K; Blajer B; Bednarek-Skublewska A
Pol Arch Med Wewn; 2005 Apr; 113(4):334-40. PubMed ID: 16209247
[TBL] [Abstract][Full Text] [Related]
10. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with use of disease modifying agents for rheumatoid arthritis in the National Hospital and Ambulatory Medical Care Survey.
Gaitonde P; Bozzi LM; Shaya FT
Semin Arthritis Rheum; 2018 Apr; 47(5):649-653. PubMed ID: 29153870
[TBL] [Abstract][Full Text] [Related]
12. [Disease-modifying treatment for inflammatory rheumatism in sub-Saharan Africa: outcome at 6 months of 205 Senegalese patients with rheumatoid arthritis].
Ndongo S; Pouye A; Lekpa FK; Bihéhé DM; Tiendrebeogo J; Ndao AC; Ka MM; Moreira Diop T
Med Sante Trop; 2012; 22(4):385-9. PubMed ID: 23352953
[TBL] [Abstract][Full Text] [Related]
13. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
14. Dialysis treatment in patients with rheumatoid arthritis.
Hezemans RL; Krediet RT; Arisz L
Neth J Med; 1995 Jul; 47(1):6-11. PubMed ID: 7651566
[TBL] [Abstract][Full Text] [Related]
15. Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis.
Accortt NA; Schenfeld J; Chang E; Papoyan E; Broder MS
Adv Ther; 2017 Sep; 34(9):2093-2103. PubMed ID: 28770517
[TBL] [Abstract][Full Text] [Related]
16. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
[TBL] [Abstract][Full Text] [Related]
17. Treatment of rheumatoid arthritis.
Gaffo A; Saag KG; Curtis JR
Am J Health Syst Pharm; 2006 Dec; 63(24):2451-65. PubMed ID: 17158693
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis: an overview of new and emerging therapies.
Doan T; Massarotti E
J Clin Pharmacol; 2005 Jul; 45(7):751-62. PubMed ID: 15951465
[TBL] [Abstract][Full Text] [Related]
19. [Secondary amyloidosis in patients with rheumatoid arthritis].
Yasuda M
Nihon Rinsho; 2005 May; 63 Suppl 5():386-90. PubMed ID: 15954381
[No Abstract] [Full Text] [Related]
20. Use of etanercept in a patient with rheumatoid arthritis on hemodialysis.
Sugioka Y; Inui K; Koike T
Mod Rheumatol; 2008; 18(3):293-5. PubMed ID: 18299957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
